Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Flavivirus envelope protein (E protein) is the primary structural component on the surface of flaviviruses, including Dengue, Zika, and West Nile viruses (PMID: 35412141). It is a class II fusion protein that mediates both the initial attachment of the virus to host cell receptors and the subsequent fusion of the viral and endosomal membranes (PMID: 18602144). On the mature virion, the E protein exists as 90 head-to-tail homodimers arranged in a herringbone pattern (PMC5894644). Upon exposure to the acidic environment of the endosome, the protein undergoes a dramatic conformational change, transitioning from a dimer to a fusogenic trimer that inserts its fusion loop into the host membrane (PMID: 22231303). This process is a critical step in the viral life cycle and is the primary target for neutralizing antibodies and experimental entry inhibitors (PMID: 35412141). Small molecules and peptides targeting the E protein aim to either block receptor binding or stabilize the prefusion dimer to prevent membrane fusion (PMC5894644). However, the high genetic diversity of flaviviruses and the risk of antibody-dependent enhancement (ADE) present significant challenges for therapeutic development (PMID: 18602144).
Inhibition of viral attachment to host receptors and prevention of pH-dependent membrane fusion by stabilizing the prefusion dimer or blocking the fusion loop.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flavivirus envelope protein (E protein) (E protein).